Turning Point Therapeutics Inc. (TPTX) Return on Investment ROI from the second quarter of 2022 to second quarter of 2021 and for the year 2022, average high and low, overall ranking from Jun 30 2022 to Jun 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Turning Point Therapeutics Inc.  (NASDAQ: TPTX)


Turning Point Therapeutics's ROI from its second quarter of 2022 to the second quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Turning Point Therapeutics's ROI in the second quarter of 2022?
Turning Point Therapeutics Inc. recorded a cumulative net loss of $-342 million during 12 months ending in the second quarter of 2022, resulting in a negative return on investment (ROI) of -37.45%.

Within the Healthcare sector 601 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2022 from 0 to 4508.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter
Y / Y Investment Change TTM -8.16 % 8.45 % 42.54 % 95.44 % 107.62 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 793 891 954 1,017 1,068
Return On Investment (TTM) -37.45 % -28.04 % -22.85 % -19.13 % -15.76 %
TPTX's Overall Ranking # 4508 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -6.98 % -5.07 % -3.64 % 7.93 % 9.84 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -342 -275 -237 -205 -157

TPTX Company Profile >> Back to TPTX Roi Comparisons >> See Annual TPTX Return On Investment



Return On Investment TPTX's Ranking
Within: No.
Industry # 246
Sector # 602
Overall # 4508

Return On Investment Statistics
High Average Low
-15.7 %
-26.08 %
-37.37 %
(Jun 30 2021)   (Jun 30 2022)







Financial Statements
Turning Point Therapeutics's II. Quarter Investments $ 793 Millions TPTX's Balance sheet
Turning Point Therapeutics's II. Quarter Income $ -123 Millions Quarterly TPTX's Income Statement
TPTX's Income by Division See TPTX's Income by Division


TPTX Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019

Total Investments in Millions 954 1,111 404 0 0
Y / Y Investment Growth -14.07 % 174.69 % - - -
Net Income in Millions -237 -157 -72 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -24.78 % -14.16 % -17.84 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TPTX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TPTX's Competitors
Subscribers only: Roi for Turning Point Therapeutics's Suppliers
Subscribers only: Return On Investment for TPTX's Customers

Other Ratios
TPTX's Roa TPTX's Inventory Turnover Ratio TPTX's Growth Rates TPTX's Dividend Statistics
TPTX's Profitability Ratios TPTX's Asset Turnover Ratio TPTX's Dividend Growth
TPTX's Roe TPTX's Valuation Ratios TPTX's Financial Strength Ratios TPTX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2022, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.